Authors:
Monali Tayade, Jignesh Rawal
Download free PDF
Nuclear Imaging Devices Market Size & Share 2023 to 2032
Report ID: GMI5861
|
Published Date: May 2023
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Jump to Content
Market Size
Market Trends
Market Analysis
Market Share
Market Companies
Industry News
Table of Contents
Frequently Asked Questions
Research Methodology
Related Reports
Download Free PDF
Nuclear Imaging Devices Market
Get a free sample of this report
Get a free sample of this report Nuclear Imaging Devices Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
Nuclear Imaging Devices Market Size
Nuclear Imaging Devices Market size was valued at over USD 3 billion in 2022 and is anticipated to grow at a CAGR of over 4.9% between 2023 and 2032. Growing demand for non-invasive diagnostic tools along with rising emphasis on personalized medicine, thereby impelling the demand for nuclear imaging devices industry.
Nuclear Imaging Devices Market Key Takeaways
The industry refers to the segment of the medical imaging industry that involves the use of radioactive tracers and specialized imaging equipment to visualize and assess the physiological and metabolic functions of organs and tissues within the human body. Nuclear imaging techniques utilize radiopharmaceuticals that emit gamma rays or positrons, which are detected by dedicated imaging devices to create images and provide functional information. The market is driven by several factors such as the increasing prevalence of chronic diseases, technological advancements in imaging systems and radiopharmaceuticals.
Rapid technological advancements in nuclear imaging offering better imaging capabilities, improve patient outcomes will drive overall growth of the industry. Also, emergence of hybrid imaging systems with combination of the functional imaging capabilities of nuclear imaging modalities like SPECT and PET with anatomical imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI). Hybrid systems, such as PET/CT and SPECT/CT provide comprehensive and precise imaging by merging functional and structural information and allows improved diagnostic accuracy, better localization of abnormalities and enhanced patient management. In addition, several market players are emphasizing on research and development activities for the development of novel nuclear imaging devices will accelerate industry expansion.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the nuclear imaging devices market. Due to the prioritization of resources and efforts towards managing and containing the spread of the virus, the demand for non-essential medical procedures experienced a temporary decline. Many healthcare facilities postponed or rescheduled elective imaging procedures to minimize the risk of virus transmission and conserve resources for COVID-19 patients. However, several governments categorized nuclear imaging procedure as essential medical procedure for detection of COVID-19 thereby experienced significant product demand. The increased need for accurate diagnosis, treatment planning, and disease monitoring, coupled with advancements in technology and emphasis on personalized medicine, are some of the factors accelerated market demand to some extent.
Nuclear Imaging Devices Market Trends
Growing several chronic disease burdens across the globe is major factor driving overall industry growth. Surging prevalence rate of several diseases such as cardiovascular disorders, cancer, neurologic conditions, and metabolic disorders requiring advanced diagnostic tools for accurate assessment and management. Nuclear imaging plays a crucial role in the diagnosis, staging, and monitoring of these diseases, providing valuable functional and metabolic information. With the rise in chronic diseases, the demand for nuclear imaging devices is anticipated to witness unprecedented growth opportunities. Moreover, rising preference for nuclear imaging such as SPECT and PET by healthcare providers to obtain detailed insights into disease progression, treatment response, and patient outcomes.
Nuclear Imaging Devices Market Analysis
Based on product type, the nuclear imaging devices market is segmented into single photon emission computed tomography (SPECT), positron emission tomography (PET), planar scintigraphy and others. Further, SPECT is segregated into standalone SPECT and hybrid SPECT/CT. PET is subdivided into standalone PET and hybrid PET/CT. SPECT segment is anticipated to exhibit enormous growth over the estimated period. Growing development of hybrid SPECT/CT systems, which combine the functional information provided by SPECT with the anatomical details obtained from CT scans. This integration allows for more precise localization and characterization of abnormalities and improved diagnostic accuracy will foster segmental growth. Moreover, utilization of advanced reconstruction algorithms, such as iterative reconstruction techniques to enhance image quality, reduce noise and improve quantitative accuracy in SPECT imaging.
The nuclear imaging devices market by application is segmented into oncology, cardiology, neurology, and others. The oncology segment was accounted for more than 49% market share in the year 2022. Increasing usage of positron emission tomography imaging for diagnosis, treatment planning, and response assessment of various cancers will fortify segment revenue size. Furthermore, advancements in image reconstruction algorithms and quantitative analysis techniques are enhancing the accuracy and reliability of oncologic imaging, aiding in treatment selection and personalized medicine approaches. With the rising incidence rate of cancer globally is poised to drive overall business growth.
Nuclear imaging devices market by end-use is subdivided into hospitals, diagnostic imaging centers, and others. The hospitals segment garnered notable market share and accounted for more than USD 1 billion revenue size in 2022. Integration of nuclear imaging devices within the hospital infrastructure to allow seamless workflow and streamlined patient care will accelerate the segmental growth potential. Hospitals are investing in advanced nuclear imaging systems such as SPECT and PET scanners to enhance their diagnostic capabilities and provide comprehensive imaging services is anticipated to boost product demand.
Additionally, growing emphasis on multidisciplinary collaboration within hospitals, where nuclear medicine departments work closely with other specialties such as oncology, cardiology, and neurology to facilitate integrated patient care. This collaborative approach ensures optimal utilization of nuclear imaging devices and enables more accurate diagnosis, treatment planning, and monitoring of patients is expected to bolster segmental growth potential.
U.S. nuclear imaging devices market accounted for more than USD 950 million in 2022 and will grow lucratively to reach more than USD 1,505 million by 2032. Increasing prevalence of chronic diseases, technological advancements, the shift towards personalized medicine and the integration of remote monitoring and telehealth solutions are some of the few aspects accelerating overall market growth in the U.S. Increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions in the U.S. will boost industry revenue size. Additionally, technological advancements in nuclear imaging such as hybrid imaging systems with improved image reconstruction algorithms are further propelling the market. Further, the region's high healthcare spending on health care management and rising disposable income will propel the expansion of the U.S. market expansion.
Nuclear Imaging Devices Market Share
Some of the notable key industry players operating in the nuclear imaging devices market include
These market participants are implementing several growth strategies such as partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen product offerings as well as gain a competitive edge over others. ss
Nuclear Imaging Devices Industry News:
Nuclear imaging devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product Type
By End-use
By End User (USD Million)
The above information is provided for the following regions and countries:
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Nuclear Imaging Devices Industry Insights
Chapter 4 Competitive landscape, 2022
Chapter 5 Nuclear Imaging Devices Market and Forecast, By Product Type (USD Million)
Chapter 6 Nuclear Imaging Devices Market and Forecast, By Application (USD Million)
Chapter 7 Nuclear Imaging Devices Market and Forecast, By End User (USD Million)
Chapter 8 Nuclear Imaging Devices Market and Forecast, By Region (USD Million)
Chapter 9 Company Profiles
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →